Affimed Therapeutics B V shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Affimed Therapeutics B V
Tip: Access up to 7 years of quarterly data
All positions including Affimed Therapeutics B V held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Affimed Therapeutics B V by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $123 | 199 | 0.62 |
| 2023-09-30 | $14k | 29k | 0.48 |
| 2023-06-30 | $3.5k | 5.9k | 0.60 |
| 2023-03-31 | $4.0k | 5.6k | 0.71 |
| 2022-12-31 | $106k | 90k | 1.17 |
| 2022-06-30 | $227k | 83k | 2.72 |
| 2022-03-31 | $300k | 69k | 4.36 |
| 2021-12-31 | $308k | 56k | 5.54 |
| 2021-03-31 | $855k | 108k | 7.92 |
| 2020-12-31 | $219k | 38k | 5.82 |
| 2020-09-30 | $0 | 30k | 0.00 |
| 2020-06-30 | $0 | 25k | 0.00 |
| 2020-03-31 | $0 | 24k | 0.00 |
| 2019-12-31 | $66k | 24k | 2.75 |
| 2019-09-30 | $58k | 20k | 2.94 |
| 2019-06-30 | $47k | 17k | 2.84 |
| 2017-12-31 | $29k | 22k | 1.31 |
| 2016-12-31 | $7.0k | 3.7k | 1.88 |
| 2016-09-30 | $28k | 10k | 2.78 |